Literature DB >> 391253

Nefopam in postoperative pain.

G Phillips, M D Vickers.   

Abstract

Three comparable groups of surgical patients were given nefopam 0.2 mg kg-1 or 0.4 mg kg-1 or morphine 0.15 mg kg-1 for pain relief after operation. Nefopam 0.4 mg kg-1 was equi-analgesic with morphine 0.15 mg kg-1 and produced no obvious cardiovascular or respiratory side-effects.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 391253     DOI: 10.1093/bja/51.10.961

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  7 in total

1.  [Not Available].

Authors:  I Jurna
Journal:  Schmerz       Date:  1988-06       Impact factor: 1.107

Review 2.  Nefopam: a review of its pharmacological properties and therapeutic efficacy.

Authors:  R C Heel; R N Brogden; G E Pakes; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-04       Impact factor: 9.546

3.  Continuous infusion of papaveretum for relief of postoperative pain.

Authors:  S K Saha
Journal:  Postgrad Med J       Date:  1981-11       Impact factor: 2.401

4.  Effective dose of nefopam in 80% of patients (ED80): a study using the continual reassessment method.

Authors:  Hélène Beloeil; Mathilde Eurin; Aude Thévenin; Dan Benhamou; Jean-Xavier Mazoit
Journal:  Br J Clin Pharmacol       Date:  2007-06-19       Impact factor: 4.335

5.  Intraoperative Nefopam Reduces Acute Postoperative Pain after Laparoscopic Gastrectomy: a Prospective, Randomized Study.

Authors:  Hyo-Seok Na; Ah-Young Oh; Jung-Hee Ryu; Bon-Wook Koo; Sun-Woo Nam; Jihoon Jo; Jae-Hee Park
Journal:  J Gastrointest Surg       Date:  2018-01-26       Impact factor: 3.452

Review 6.  Single dose oral nefopam for acute postoperative pain in adults.

Authors:  Manish Kakkar; Sheena Derry; R Andrew Moore; Henry J McQuay
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

7.  Association of nefopam use with postoperative nausea and vomiting in gynecological patients receiving prophylactic ramosetron: A retrospective study.

Authors:  Sun-Kyung Park; Seokha Yoo; Won Ho Kim; Young-Jin Lim; Jae-Hyon Bahk; Jin-Tae Kim
Journal:  PLoS One       Date:  2018-06-28       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.